UroGen Pharma Ltd. ($URGN)
Filing Information
| Accession Number | 0001437749-26-003778 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 11, 2026 |
| Document Date | Jan 31, 2026 |
| Document | View SEC Filing |
Transactions
10
Total Shares
71,088
Total Value
$147,261.51
P&L
+inf% (+$601,309.96)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
General Counsel | Ordinary Shares | โ | Jan 31, 2026 | Exercise/Conversion | 5,500 | โ | โ | 55,472 | Direct | โ | View Details | |
General Counsel | Ordinary Shares | โ | Feb 3, 2026 | Sale | 2,654 | $19.69 | $52,257.26 | 52,934 | Direct | โ | View Details | |
General Counsel | Ordinary Shares | โ | Jan 31, 2026 | Exercise/Conversion | 3,333 | โ | โ | 58,805 | Direct | โ | View Details | |
General Counsel | Ordinary Shares | โ | Feb 3, 2026 | Sale | 1,608 | $19.69 | $31,661.52 | 51,326 | Direct | โ | View Details | |
General Counsel | Ordinary Shares | โ | Jan 31, 2026 | Exercise/Conversion | 6,667 | โ | โ | 49,972 | Direct | โ | View Details | |
General Counsel | Ordinary Shares | โ | Feb 3, 2026 | Sale | 3,217 | $19.69 | $63,342.73 | 55,588 | Direct | โ | View Details | |
General Counsel | Restricted Stock Units | Derivative | Jan 31, 2026 | Exercise/Conversion | 5,500 | $0.00 | $0.00 | 5,500 | Direct | โ | View Details | |
General Counsel | Restricted Stock Units | Derivative | Jan 31, 2026 | Exercise/Conversion | 3,333 | $0.00 | $0.00 | 6,667 | Direct | โ | View Details | |
General Counsel | Restricted Stock Units | Derivative | Jan 31, 2026 | Exercise/Conversion | 6,667 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
General Counsel | Restricted Stock Units | Derivative | Jan 31, 2026 | Grant/Award | 32,609 | $0.00 | $0.00 | 32,609 | Direct | โ | View Details |